Search Results

There are 10207 results for: content related to: Suitability of digoxin as a P-glycoprotein probe: Implications of other transporters on sensitivity and specificity

  1. Assessment of P-Glycoprotein Substrate and Inhibition Potential of Test Compounds in MDR1-Transfected MDCK Cells

    Unit

    Current Protocols in Pharmacology

    7:7.13.1–7.13.17

    Kevin C. L. Lam and Ganesh Rajaraman

    Published Online : 1 SEP 2012, DOI: 10.1002/0471141755.ph0713s58

  2. You have free access to this content
    The Pharmacology and Therapeutic Use of Dabigatran Etexilate

    The Journal of Clinical Pharmacology

    Volume 53, Issue 1, January 2013, Pages: 1–13, Spinler Sarah

    Version of Record online : 24 JAN 2013, DOI: 10.1177/0091270011432169

  3. Introduction to Drug Transporters

    Standard Article

    Pharmaceutical Sciences Encyclopedia

    Louis Leung and Aram Oganesian

    Published Online : 15 MAR 2010, DOI: 10.1002/9780470571224.pse105

  4. You have free access to this content
    Influence of drug transport proteins on the pharmacokinetics and drug interactions of HIV protease inhibitors

    Journal of Pharmaceutical Sciences

    Volume 100, Issue 9, September 2011, Pages: 3636–3654, Latoya Griffin, Pieter Annaert and Kim L.R. Brouwer

    Version of Record online : 22 JUN 2011, DOI: 10.1002/jps.22655

  5. Polymorphisms in Human MDR1 (P-glycoprotein): Recent Advances and Clinical Relevance

    Clinical Pharmacology & Therapeutics

    Volume 75, Issue 1, January 2004, Pages: 13–33, Catia Marzolini, Erik Paus, Thierry Buclin and Richard B. Kim

    Version of Record online : 22 JAN 2004, DOI: 10.1016/j.clpt.2003.09.012

  6. Review of P-gp Inhibition Data in Recently Approved New Drug Applications: Utility of the Proposed [I1]/IC50 and [I2]/IC50 Criteria in the P-gp Decision Tree

    The Journal of Clinical Pharmacology

    Volume 53, Issue 2, February 2013, Pages: 228–233, Sheetal Agarwal, Vikram Arya and Lei Zhang

    Version of Record online : 22 FEB 2013, DOI: 10.1177/0091270011436344

  7. Enzyme- and transporter-mediated beverage–drug interactions: An update on fruit juices and green tea

    The Journal of Clinical Pharmacology

    Volume 55, Issue 12, December 2015, Pages: 1313–1331, Guohua An, Jatinder Kaur Mukker, Hartmut Derendorf and Reginald F. Frye

    Version of Record online : 30 JUL 2015, DOI: 10.1002/jcph.563

  8. Clinical drug interaction profile of idelalisib in healthy subjects

    The Journal of Clinical Pharmacology

    Volume 55, Issue 8, August 2015, Pages: 909–919, Feng Jin, Michelle Robeson, Huafeng Zhou, Candra Moyer, Sibylle Wilbert, Bernard Murray and Srini Ramanathan

    Version of Record online : 6 MAY 2015, DOI: 10.1002/jcph.495

  9. You have free access to this content
    Evaluation of documented drug interactions and contraindications associated with herbs and dietary supplements: a systematic literature review

    International Journal of Clinical Practice

    Volume 66, Issue 11, November 2012, Pages: 1056–1078, H.-H. Tsai, H.-W. Lin, A. Simon Pickard, H.-Y. Tsai and G. B. Mahady

    Version of Record online : 16 OCT 2012, DOI: 10.1111/j.1742-1241.2012.03008.x

  10. Pomalidomide: Evaluation of cytochrome P450 and transporter-mediated drug–drug interaction potential in vitro and in healthy subjects

    The Journal of Clinical Pharmacology

    Volume 55, Issue 2, February 2015, Pages: 168–178, Claudia Kasserra, Mahmoud Assaf, Matthew Hoffmann, Yan Li, Liangang Liu, Xiaomin Wang, Gondi Kumar and Maria Palmisano

    Version of Record online : 7 SEP 2014, DOI: 10.1002/jcph.384

  11. Clinical drug-drug interaction assessment of ivacaftor as a potential inhibitor of cytochrome P450 and P-glycoprotein

    The Journal of Clinical Pharmacology

    Volume 55, Issue 1, January 2015, Pages: 56–62, Sarah M. Robertson, Xia Luo, Neeraj Dubey, Chonghua Li, Ajit B. Chavan, Geoffrey S. Gilmartin, Mark Higgins and Lisa Mahnke

    Version of Record online : 27 AUG 2014, DOI: 10.1002/jcph.377

  12. You have free access to this content
    A cohort study of digoxin exposure and mortality in men with prostate cancer

    BJU International

    Volume 113, Issue 2, February 2014, Pages: 236–245, Evelyn M. Flahavan, Linda Sharp, Kathleen Bennett and Thomas I. Barron

    Version of Record online : 13 AUG 2013, DOI: 10.1111/bju.12287

  13. Effects of Multiple Doses of Ambrisentan on the Pharmacokinetics of a Single Dose of Digoxin in Healthy Volunteers

    The Journal of Clinical Pharmacology

    Volume 51, Issue 1, January 2011, Pages: 102–106, Dr Duncan B. Richards, Dr Rebecca Spence, Dr Arun Mandagere, Dr Linda S. Henderson and Dr Mindy H. Magee

    Version of Record online : 8 MAR 2013, DOI: 10.1177/0091270010362693

  14. Is Foxglove Effective in Heart Failure?

    Cardiovascular Therapeutics

    Volume 33, Issue 4, August 2015, Pages: 236–241, Parminder S Chaggar, Steven M Shaw and Simon G Williams

    Version of Record online : 7 JUL 2015, DOI: 10.1111/1755-5922.12130

  15. Digoxin use after diagnosis of prostate cancer and survival: a population-based cohort study

    Pharmacoepidemiology and Drug Safety

    Reema A. Karasneh, Liam J. Murray, Carmel M. Hughes and Chris R. Cardwell

    Version of Record online : 4 MAY 2016, DOI: 10.1002/pds.4018

  16. Digitalis in the Elderly

    Journal of the American Geriatrics Society

    Volume 37, Issue 9, September 1989, Pages: 873–882, Arshag D. Mooradian, Vicki L. Grieff, Rubin Bressler, Richard L. Reed and Frank I. Marcus

    Version of Record online : 27 APR 2015, DOI: 10.1111/j.1532-5415.1989.tb02269.x

  17. You have free access to this content
    Do Children Have the Same Vulnerability to Metabolic Drug–Drug Interactions as Adults? A Critical Analysis of the Literature

    The Journal of Clinical Pharmacology

    Volume 53, Issue 5, May 2013, Pages: 559–566, Farzaneh Salem, Amin Rostami-Hodjegan and Trevor N. Johnson

    Version of Record online : 20 FEB 2013, DOI: 10.1002/jcph.13

  18. You have free access to this content
    Requirement for cardiac telemetry during intravenous phenytoin infusion: guideline fact or guideline fiction?

    Internal Medicine Journal

    Volume 43, Issue 1, January 2013, Pages: 7–17, W. J. Siebert and A. D. McGavigan

    Version of Record online : 17 JAN 2013, DOI: 10.1111/j.1445-5994.2012.02935.x

  19. You have free access to this content
    Meta-analysis of the influence of MDR1 C3435T polymorphism on digoxin pharmacokinetics and MDR1 gene expression

    British Journal of Clinical Pharmacology

    Volume 60, Issue 2, August 2005, Pages: 159–171, Balram Chowbay, Huihua Li, Machin David, Yin Bun Cheung and Edmund J. D. Lee

    Version of Record online : 6 MAY 2005, DOI: 10.1111/j.1365-2125.2005.02392.x

  20. Preventing drug-related morbidity – the development of quality indicators

    Journal of Clinical Pharmacy and Therapeutics

    Volume 28, Issue 4, August 2003, Pages: 295–305, C. J. Morris and J. A. Cantrill

    Version of Record online : 11 AUG 2003, DOI: 10.1046/j.1365-2710.2003.00496.x